LIPES (2016–2021) directly targeted enzymatic splitting of triglycerides, the foundational feedstock transformation in Oleon's industrial business.
OLEON
French industrial oleochemical manufacturer specializing in enzymatic and chemoenzymatic processing of vegetable oils into bio-based commodity and fine chemicals.
Their core work
OLEON (operating through its French R&D center Novance in Venette) is a European industrial oleochemical manufacturer that converts vegetable oils and animal fats — primarily triglycerides — into fatty acids, glycerol, esters, and specialty chemicals for use across food, cosmetics, lubricants, and industrial markets. Their core industrial competence spans both conventional and enzymatic processing routes for triglyceride hydrolysis and downstream chemical derivatization, at genuine manufacturing scale. In EU research projects they participate as an industrial third party, contributing production infrastructure, bio-based feedstock access, and process know-how that bridges laboratory findings with real-world manufacturing constraints. Their project involvement reflects a deliberate strategic interest in greener, more efficient chemoenzymatic routes to both high-volume commodity oleochemicals and higher-value fine chemicals.
What they specialise in
INCITE (2019–2023) combined chemical and enzymatic steps into end-to-end integrated processes for producing both commodity and fine chemicals from bio-based feedstocks.
INCITE's keyword set — commodity chemicals, fine chemicals, integrated downstream processing — shows a move toward higher-value product portfolios beyond bulk oleochemicals.
Both LIPES and INCITE explicitly address integrated downstream processing, a domain where Oleon contributes real manufacturing infrastructure rather than lab-only expertise.
How they've shifted over time
In their earliest H2020 project (LIPES, 2016), the focus was squarely on enzymatic splitting of triglycerides — a greener alternative to conventional high-temperature, high-pressure chemical hydrolysis — framed within a food and agriculture context with no broader chemical portfolio ambition. By INCITE (2019), the scope had broadened markedly: the project targets integrated chemoenzymatic workflows producing both high-volume commodity chemicals and specialty fine chemicals, indicating a deliberate expansion from single-step feedstock conversion toward end-to-end process integration. The trajectory is clear: from mastering one green unit operation (enzymatic splitting) toward designing entire biorefinery-style process chains that can serve multiple chemical markets.
OLEON is moving from single-step green processing of fats toward full chemoenzymatic process integration — suggesting future collaboration interest in biorefinery design, specialty bio-based chemicals, and sustainable industrial chemistry at production scale.
How they like to work
OLEON has participated exclusively as a third party in both H2020 projects, meaning they contribute industrial expertise and facilities under a subcontracting or linked-entity arrangement rather than as a named consortium member drawing direct EU funding. This is a pattern common among large industrial companies that support academic-led research with real-world infrastructure without taking on project management responsibility. Their consistent third-party positioning suggests they are best approached as an industrial validation or scale-up partner, not as a project coordinator or administrative lead.
Across two projects, OLEON has worked alongside 15 unique consortium partners spanning 6 countries, which is a relatively broad network for an organization with only two H2020 engagements. Their involvement in BBI-funded projects (Bio-Based Industries) suggests connections into the European bio-economy consortium ecosystem, including research institutes, universities, and other industrial players in the vegetable oil and biochemistry space.
What sets them apart
OLEON occupies a rare position in European bio-based chemistry: they are one of the continent's significant industrial oleochemical producers, which means they bring actual production-scale triglyceride processing infrastructure — not just laboratory knowledge — to research consortia. Where most academic or SME partners can demonstrate a process at pilot scale, OLEON can validate it against real industrial constraints, feedstock variability, and cost structures. For any consortium developing enzymatic or chemoenzymatic routes to bio-based chemicals, access to an industrial fatty acid and oleochemical production environment is a significant asset that is difficult to replicate with other partners.
Highlights from their portfolio
- INCITEThe most technically ambitious of OLEON's projects, targeting fully integrated chemoenzymatic production of both commodity and fine chemicals — a process-design challenge at the frontier of industrial green chemistry.
- LIPESA BBI demonstration-scale project on enzymatic triglyceride splitting, placing OLEON's industrial feedstock base at the center of a multi-partner effort to replace conventional chemical hydrolysis with a greener enzymatic route.